{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:25:41Z","timestamp":1789662341857,"version":"4.0.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":2354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1038\/modpathol.2016.78","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T08:02:07Z","timestamp":1461916927000},"page":"810-823","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Elevated expression of chemokine C-C ligand 2 in stroma is associated with recurrent basal-like breast cancers"],"prefix":"10.1016","volume":"29","author":[{"given":"Min","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Staggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2016.78_bib1","first-page":"87","article-title":"Global cancer statistics 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1038\/modpathol.2016.78_bib2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/path.2808","article-title":"The molecular pathology of breast cancer progression","volume":"223","author":"Bombonati","year":"2011","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2016.78_bib3","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.soncn.2007.10.003","article-title":"Overcoming treatment challenges in advanced breast cancer","volume":"23","author":"Harkins","year":"2007","journal-title":"Semin Oncol Nurs"},{"key":"10.1038\/modpathol.2016.78_bib4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10549-008-0032-3","article-title":"Treatment of metastatic breast cancer: looking towards the future","volume":"114","author":"Amar","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1038\/modpathol.2016.78_bib5","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s12032-013-0615-7","article-title":"Outcomes of locally advanced breast cancer patients with >\/= 10 positive axillary lymph nodes","volume":"30","author":"Koca","year":"2013","journal-title":"Med Oncol"},{"key":"10.1038\/modpathol.2016.78_bib6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12282-011-0276-3","article-title":"Improvement of survival and prospect of cure in patients with metastatic breast cancer","volume":"19","author":"Cheng","year":"2012","journal-title":"Breast Cancer"},{"key":"10.1038\/modpathol.2016.78_bib7","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1073\/pnas.0932692100","article-title":"Repeated observation of breast tumor subtypes in independent gene expression data sets","volume":"100","author":"Sorlie","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2016.78_bib8","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"Sorlie","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2016.78_bib9","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/jnci\/djp082","article-title":"Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer","volume":"101","author":"Cheang","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/modpathol.2016.78_bib10","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1186\/bcr3084","article-title":"Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer","volume":"14","author":"Aleskandarany","year":"2012","journal-title":"Breast Cancer Res"},{"key":"10.1038\/modpathol.2016.78_bib11","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.hoc.2013.05.012","article-title":"Tailoring adjuvant treatments for the individual patient with luminal breast cancer","volume":"27","author":"Munzone","year":"2013","journal-title":"Hematol Oncol Clin North Am"},{"issue":"Suppl 1","key":"10.1038\/modpathol.2016.78_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1634\/theoncologist.2011-S1-01","article-title":"Triple-negative breast cancer: an unmet medical need","volume":"16","author":"Hudis","year":"2011","journal-title":"Oncologist"},{"key":"10.1038\/modpathol.2016.78_bib13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1046\/j.1440-1827.2000.01035.x","article-title":"New prognostic histological parameter of invasive ductal carcinoma of the breast: clinicopathological significance of fibrotic focus","volume":"50","author":"Hasebe","year":"2000","journal-title":"Pathol Int"},{"key":"10.1038\/modpathol.2016.78_bib14","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/bjc.1974.62","article-title":"Fibrosis as in indication of time in infiltrating breast cancer and its importance in prognosis","volume":"29","author":"Anastassiades","year":"1974","journal-title":"Br J Cancer"},{"key":"10.1038\/modpathol.2016.78_bib15","first-page":"263","article-title":"Prognostic significance of desmoplasia in breast carcinoma. A preliminary clinical study","volume":"18","author":"Mezi","year":"1997","journal-title":"G Chir"},{"key":"10.1038\/modpathol.2016.78_bib16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1083\/jcb.130.2.393","article-title":"Identification and characterization of a fibroblast marker: FSP1","volume":"130","author":"Strutz","year":"1995","journal-title":"J Cell Biol"},{"key":"10.1038\/modpathol.2016.78_bib17","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.4161\/cbt.5.12.3354","article-title":"Identification of fibroblast heterogeneity in the tumor microenvironment","volume":"5","author":"Sugimoto","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"10.1038\/modpathol.2016.78_bib18","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/1471-2407-12-306","article-title":"The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients","volume":"12","author":"Medrek","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1038\/modpathol.2016.78_bib19","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in cancer","volume":"6","author":"Kalluri","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/modpathol.2016.78_bib20","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ccr.2008.03.007","article-title":"Regulation of in situ to invasive breast carcinoma transition","volume":"13","author":"Hu","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1038\/modpathol.2016.78_bib21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","article-title":"Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion","volume":"121","author":"Orimo","year":"2005","journal-title":"Cell"},{"key":"10.1038\/modpathol.2016.78_bib22","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1172\/JCI26532","article-title":"Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake","volume":"116","author":"Loeffler","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1038\/modpathol.2016.78_bib23","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/jnci\/djs336","article-title":"Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug","volume":"104","author":"Brennen","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/modpathol.2016.78_bib24","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.ijrobp.2009.12.009","article-title":"Management of inflammatory breast cancer after neoadjuvant chemotherapy","volume":"79","author":"Abrous-Anane","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1038\/modpathol.2016.78_bib25","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nm1764","article-title":"Stromal gene expression predicts clinical outcome in breast cancer","volume":"14","author":"Finak","year":"2008","journal-title":"Nat Med"},{"key":"10.1038\/modpathol.2016.78_bib26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2004.06.010","article-title":"Molecular characterization of the tumor microenvironment in breast cancer","volume":"6","author":"Allinen","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1038\/modpathol.2016.78_bib27","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/path.3029","article-title":"The chemokine system and cancer","volume":"226","author":"Balkwill","year":"2012","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2016.78_bib28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1124\/pr.111.005074","article-title":"CC chemokine receptors and chronic inflammation\u2014therapeutic opportunities and pharmacological challenges","volume":"65","author":"White","year":"2013","journal-title":"Pharmacol Rev"},{"key":"10.1038\/modpathol.2016.78_bib29","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jdermsci.2013.07.008","article-title":"Current understanding of molecular and cellular mechanisms in fibroplasia and angiogenesis during acute wound healing","volume":"72","author":"Greaves","year":"2013","journal-title":"J Dermatol Sci"},{"key":"10.1038\/modpathol.2016.78_bib30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10585-011-9373-0","article-title":"Loss of one Tgfbr2 allele in fibroblasts promotes metastasis in MMTV: polyoma middle T transgenic and transplant mouse models of mammary tumor progression","volume":"28","author":"Fang","year":"2011","journal-title":"Clin Exp Metastasis"},{"key":"10.1038\/modpathol.2016.78_bib31","doi-asserted-by":"crossref","first-page":"36593","DOI":"10.1074\/jbc.M112.365999","article-title":"CCL2\/CCR2 chemokine signaling coordinates survival and motility of breast cancer cells through Smad3 protein- and p42\/44 mitogen-activated protein kinase (MAPK)-dependent mechanisms","volume":"287","author":"Fang","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1038\/modpathol.2016.78_bib32","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/ijc.24378","article-title":"Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression","volume":"125","author":"Fujimoto","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.2016.78_bib33","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10138","article-title":"CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis","volume":"475","author":"Qian","year":"2011","journal-title":"Nature"},{"key":"10.1038\/modpathol.2016.78_bib34","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1593\/neo.10200","article-title":"Loss of transforming growth factor-beta signaling in mammary fibroblasts enhances CCL2 secretion to promote mammary tumor progression through macrophage-dependent and -independent mechanisms","volume":"12","author":"Hembruff","year":"2010","journal-title":"Neoplasia"},{"key":"10.1038\/modpathol.2016.78_bib35","first-page":"3282","article-title":"Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer","volume":"6","author":"Ueno","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2016.78_bib36","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00432-004-0667-3","article-title":"Macrophage level is not affected by monocyte chemotactic protein-1 in invasive ductal breast carcinoma","volume":"131","author":"Valkovic","year":"2005","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1038\/modpathol.2016.78_bib37","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10549-015-3324-4","article-title":"The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells","volume":"150","author":"Fang","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1038\/modpathol.2016.78_bib38","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1186\/1471-2407-14-781","article-title":"Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-beta signaling proteins","volume":"14","author":"Zou","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1038\/modpathol.2016.78_bib39","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1746-1596-7-42","article-title":"Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring","volume":"7","author":"Rizzardi","year":"2012","journal-title":"Diagn Pathol"},{"key":"10.1038\/modpathol.2016.78_bib40","first-page":"124","article-title":"Cox models survival analysis based on breast cancer treatments","volume":"7","author":"Abadi","year":"2014","journal-title":"Iran J Cancer Prev"},{"key":"10.1038\/modpathol.2016.78_bib41","doi-asserted-by":"crossref","unstructured":"Morrow M, Krontiras H . Who should not receive chemotherapy? Data from American databases and trials. J Natl Cancer Inst Monogr 2001;109\u2013113.","DOI":"10.1093\/oxfordjournals.jncimonographs.a003446"},{"key":"10.1038\/modpathol.2016.78_bib42","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1089\/jwh.2010.2114","article-title":"Factors affecting survival among women with breast cancer in Hawaii","volume":"20","author":"Maskarinec","year":"2011","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1038\/modpathol.2016.78_bib43","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1001\/archinte.165.11.1267","article-title":"Undertreatment of obese women receiving breast cancer chemotherapy","volume":"165","author":"Griggs","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1038\/modpathol.2016.78_bib44","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ctrv.2008.07.005","article-title":"Dosing chemotherapy in obese patients: actual versus assigned body surface area (BSA)","volume":"35","author":"Hunter","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"10.1038\/modpathol.2016.78_bib45","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1001\/jamaoncol.2015.3856","article-title":"Delayed initiation of adjuvant chemotherapy among patients with breast cancer","volume":"2","author":"Chavez-MacGregor","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1038\/modpathol.2016.78_bib46","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/jamaoncol.2015.4508","article-title":"Time to surgery and breast cancer survival in the United States","volume":"2","author":"Bleicher","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1038\/modpathol.2016.78_bib47","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1001\/jamaoncol.2015.4506","article-title":"Timeliness in breast cancer treatment-the sooner, the better","volume":"2","author":"Waks","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1038\/modpathol.2016.78_bib48","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/bcr2261","article-title":"Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors","volume":"11","author":"Kwan","year":"2009","journal-title":"Breast Cancer Res"},{"key":"10.1038\/modpathol.2016.78_bib49","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.breast.2015.02.030","article-title":"Translating the concept of intrinsic subtypes into an oncoplastic cohort of more than 1000 patients - predictors of recurrence and survival","volume":"24","author":"Rezai","year":"2015","journal-title":"Breast"},{"key":"10.1038\/modpathol.2016.78_bib50","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1158\/1078-0432.CCR-05-1425","article-title":"Correlations between serum monocyte chemotactic protein-1 levels, clinical prognostic factors, and HER-2\/neu vaccine-related immunity in breast cancer patients","volume":"12","author":"Dehqanzada","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2016.78_bib51","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.humpath.2006.04.015","article-title":"Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2\/neu-overexpressing phenotypes","volume":"37","author":"Kim","year":"2006","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2016.78_bib52","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","article-title":"Triple-negative breast cancer: clinical features and patterns of recurrence","volume":"13","author":"Dent","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2016.78_bib53","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/1097-0142(20010901)92:5<1085::AID-CNCR1424>3.0.CO;2-K","article-title":"Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma","volume":"92","author":"Saji","year":"2001","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2016.78_bib54","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10549-015-3291-9","article-title":"Differential expression of cancer-associated fibroblast-related proteins according to molecular subtype and stromal histology in breast cancer","volume":"149","author":"Park","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1038\/modpathol.2016.78_bib55","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1387\/ijdb.113371dl","article-title":"Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions","volume":"55","author":"Laoui","year":"2011","journal-title":"Int J Dev Biol"},{"key":"10.1038\/modpathol.2016.78_bib56","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.atherosclerosis.2012.09.013","article-title":"Distribution of macrophage polarization markers in human atherosclerosis","volume":"225","author":"Stoger","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1038\/modpathol.2016.78_bib57","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13058-015-0621-0","article-title":"Human breast cancer cells educate macrophages toward the M2 activation status","volume":"17","author":"Sousa","year":"2015","journal-title":"Breast Cancer Res"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol201678.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol201678","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222015666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222015666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol201678.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:50:42Z","timestamp":1760230242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222015666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0893395222015666"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2016.78","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated expression of chemokine C-C ligand 2 in stroma is associated with recurrent basal-like breast cancers","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2016.78","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}